Daniel Martin-Iglesias (D Martín-Iglesias, Daniel Martín-Iglesias)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Venues

Expert review of clinical immunology

The Journal of rheumatology

Lupus

International journal of rheumatic diseases

BioCruces Health research Institute

Universitat de Barcelona (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

BioCruces Health research Institute - Feb 20 2019

Spain

Reseacher :: Autoimmune Diseases

Hospital Universitario de la Princesa Jun 26 2017 - Nov 07 2017

Spain

Internal Medicine Specialist :: Internal Medicine

Education History

Universitat de Barcelona

Spain

MSC

Publications

Antonio Gallardo-Pizarro, Valerio Campos-Rodríguez, Daniel Martin-Iglesias, Guillermo Ruiz-Irastorza
Routine biomarker profile for the prediction of clinical phenotypes of adult-onset Still's disease using unsupervised clustering algorithm. International journal of rheumatic diseases 27 (4) (2024)
Diana Paredes-Ruiz, Daniel Martin-Iglesias, Guillermo Ruiz-Irastorza
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus. Expert review of clinical immunology 20 (4) (2023)
Diana Paredes-Ruiz, Daniel Martin-Iglesias, Guillermo Ruiz-Irastorza
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus. Expert review of clinical immunology (2023)
Diana Paredes-Ruiz, Daniel Martin-Iglesias, Guillermo Ruiz-Irastorza
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus. Expert review of clinical immunology 20 (4) (2023)
Diana Paredes-Ruiz, Daniel Martin-Iglesias, Guillermo Ruiz-Irastorza
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus. Expert review of clinical immunology (2023)
Daniel Martin-Iglesias, Joseba Artaraz, Guillermo Ruiz-Irastorza
Hydroxychloroquine Retinal Toxicity and Its Association with Dosage. The Journal of rheumatology 48 (1) (2020)
Daniel Martin-Iglesias, J Artaraz, A Fonollosa, A Ugarte, A Arteagabeitia, Guillermo Ruiz-Irastorza
Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus. Lupus 28 (4) (2019)

Daniel Martin-Iglesias.css-eqlu8i{font-size:small;padding-left:4px;} (D Martín-Iglesias, Daniel Martín-Iglesias)

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Martin-Iglesias (D Martín-Iglesias, Daniel Martín-Iglesias)